Novel Lactone Compounds from Mortierella verticillata that Induce the Human Low Density Lipoprotein Receptor Gene:Fermentation, Isolation, Structural Elucidation and Biological Activities

Among methods of controlling hypercholesterolemia and hyperlipidemia is the direct stimulation of hepatic low density lipoprotein (LDL) receptors. Two novel lactone compounds, CJ-12, 950 and CJ-13, 357, containing an unusual oxime moiety, were isolated from a zygomycete Mortierella verticillata. The...

Full description

Saved in:
Bibliographic Details
Published inJournal of antibiotics Vol. 51; no. 1; pp. 14 - 20
Main Authors DEKKER, KOEN A., AIELLO, ROBERT J., HIRAI, HIDEO, INAGAKI, TAISUKE, SAKAKIBARA, TATSUO, SUZUKI, YUMIKO, THOMPSON, JOHN F., YAMAUCHI, YUJI, KOJIMA, NAKAO
Format Journal Article
LanguageEnglish
Published TOKYO JAPAN ANTIBIOTICS RESEARCH ASSOCIATION 01.01.1998
JAPAN ANTIBIOT RES ASSN
Japan Antibiotics Research Association
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Among methods of controlling hypercholesterolemia and hyperlipidemia is the direct stimulation of hepatic low density lipoprotein (LDL) receptors. Two novel lactone compounds, CJ-12, 950 and CJ-13, 357, containing an unusual oxime moiety, were isolated from a zygomycete Mortierella verticillata. These lactones are potent inducers of the LDL receptor gene in vitro, that enhanced LDL receptor expression in human hepatocytes 2-fold at 100nM.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0021-8820
1881-1469
DOI:10.7164/antibiotics.51.14